CHANGHAI(SZ:300196)2024-10-25 08:07Financial Performance - The company's revenue for Q3 2024 was ¥678,973,468.60, a decrease of 0.25% compared to the same period last year[2]. - Net profit attributable to shareholders for the period was ¥80,406,603.85, representing an increase of 3.83% year-on-year, while the year-to-date net profit decreased by 29.68% to ¥202,464,298.66[2]. - Basic earnings per share for the period was ¥0.20, an increase of 11.11%, while the year-to-date figure decreased by 28.57% to ¥0.50[2]. - The diluted earnings per share for the period was ¥0.19, an increase of 5.56%, while the year-to-date figure decreased by 27.94% to ¥0.49[2]. - Total operating revenue for Q3 2024 was CNY 1,902,587,303.35, a decrease of 4.26% compared to CNY 1,987,984,870.25 in the same period last year[16]. - Net profit for Q3 2024 was CNY 202,061,878.48, down 29.7% from CNY 287,520,452.97 in Q3 2023[17]. - Total comprehensive income for the period was CNY 202,061,878.48, a decrease from CNY 287,520,452.97 in the previous period[18]. Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥153,275,696.29, down 70.54% compared to the previous year[2]. - Net cash flow from operating activities dropped by 70.54% to CNY 153,275,696.29, largely due to increased payments for time deposits[8]. - Cash inflow from operating activities totaled CNY 1,917,556,336.25, compared to CNY 2,051,057,547.86 in the previous period[19]. - Cash outflow from operating activities was CNY 1,764,280,639.96, an increase from CNY 1,530,853,407.48 in the previous period[20]. - Net cash flow from investing activities was CNY -319,672,010.48, compared to CNY -531,565,438.47 in the previous period[20]. - Cash inflow from financing activities was CNY 293,837,000.00, down from CNY 661,023,020.95 in the previous period[20]. - Cash and cash equivalents at the end of the period were CNY 962,371,447.37, a decrease from CNY 1,360,869,505.43 at the end of the previous period[20]. Assets and Liabilities - Total assets at the end of the reporting period were ¥6,854,182,124.65, an increase of 8.56% from the end of the previous year[2]. - Total liabilities rose to CNY 2,286,330,548.75, up from CNY 1,854,838,593.59 in the previous year[15]. - The company's equity attributable to shareholders increased to CNY 4,573,850,918.33 from CNY 4,464,544,528.96 year-over-year[15]. - The company's financial assets decreased by 54.48% to CNY 130,364,253.70, primarily due to a reduction in bank wealth management products[7]. - Accounts receivable increased by 44.22% to CNY 601,914,122.53, mainly due to an increase in receivables[7]. - Inventory at the end of the period is ¥248,459,875.36, a decrease from ¥262,088,291.89[13]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 13,432[9]. - The largest shareholder, Yang Pengwei, holds 41.71% of shares, totaling 170,474,412 shares[9]. - The top ten shareholders include state-owned and other institutional investors, with the largest being Yang Pengwei and Yang Guowen, who are identified as acting in concert[10]. - The total number of shares held by the top ten unrestricted shareholders is 100,000,000 shares[10]. - The company has no changes in the status of pledged, marked, or frozen shares for the major shareholders[9]. Operational Insights - Operating profit decreased by 30.30% to CNY 224,587,974.66, primarily due to a decline in product sales prices[7]. - Total profit fell by 30.86% to CNY 222,473,255.44, mainly driven by lower product sales prices[7]. - Research and development expenses for Q3 2024 were CNY 89,340,459.47, compared to CNY 101,390,246.95 in the same period last year[17]. - The company plans to continue focusing on market expansion and new product development in the upcoming quarters[17].